Examples of using Use in children in English and their translations into Slovak
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
There is no experience available concerning the use in children.
Not enough evidence is available to recommend use in children.
Use in children The efficacy and safety of AZOPT in patients below the age of 18 have not been established and its use is not recommended in these patients.
The use in children under 12 years of age is not recommended because efficacy has not been sufficiently documented although specific risk in children over 1 year of age is not documented.
Use in children and adolescents under 18 years of age Olanzapine is not indicated for use in the treatment of children and adolescents.
The use in children under 12 years of age is not recommended(See Section 4.4 Special warnings and precautions for use). .
Mimpara is not indicated for use in children and adolescents due to a lack of data on safety
Use in children 2 years of age and above- Your doctor will decide
There is no information available on use in children aged less than 3 years or aged from 10-17 years.
INVEGA is not for use in children and adolescents under 15 years for the treatment of schizophrenia.
Use in children- For children, your doctor will decide the right dose(number of tablets)
With prolonged use in children can develop a high level of absorption,
The use in children between 1 and 12 years of age is not recommended, because efficacy has not been sufficiently documented although specific risks are not documented.
Use in children(aged 6 to 11 years)
There are not sufficient data to recommend the use in children and adolescents.
There is not enough evidence on its safety for use in children, however, so adults should always keep ALA in a safe place.
Panretin is not approved for use in children and adolescents under 18 years of age.
Use in children(aged 6 to 11 years)
Use in children Alendronate HEXAL is not recommended for use in children due to a lack of data on safety and efficacy.